RT @RareRevolutionM: https://edition.pagesuite-professional.co.uk/html5/reader/production/default.aspx?pnum=1&edid=aaade60a-f31e-4509-8171-fbef741f3690&isshared=true - #RareDisease #SummerEdition #Cancer #Oncology

RT @Pharmafocus: Boehringer buys #cancer vaccine company AMAL Therapeutics for €325 million http://bit.ly/2JGgrym #pharma #oncology #biot…

The cancer microbiome - Nature Reviews Cancer https://www.nature.com/articles/s41568-019-0155-3 #microbiome #microbiology #cancer #oncology

This one hits deep. #radonc #oncology https://jamanetwork.com/journals/jamaoncology/article-abstract/2738066

Addition of Antiangiogenic Agent to First-Line Carboplatin/Paclitaxel in Ovarian Cancer https://www.ascopost.com/issues/july-10-2019/addition-of-antiangiogenic-agent-to-first-line-carboplatinpaclitaxel-in-ovarian-cancer/ #gyncsm #oncology

RT @Optum: Cancer drugs make up more than 1/3 of the drug pipeline. Read more about the new age of #oncology: https://optum.co/hgskj https…

Cytori Will Become Plus Therapeutics, Inc. http://www.plustherapeutics.com/investors/ #nanomedicine #oncology #pharmaceuticals #cancertreatment

New Nanoparticles to Stop Growth of HER2-Positive Breast Cancer https://mdgdgt.com/2JL5RWT #ObGyn #Oncology https://t.co/MNMMTZlFzz

Enrollment on genomically matched clinical trials improves #sarcoma outcomes. #oncology #ASCO2019 https://www.healio.com/hematology-oncology/sarcoma/news/online/{0e97eb3b-c507-42d9-aa6c-aa0ef1f06a4f}/enrollment-on-genomically-matched-clinical-trials-improves-sarcoma-outcomes?utm_medium=social&utm_source=twitter&utm_campaign=scheduledpost

PD-L1 alterations identify T-cell inflamed diffuse large B-cell #lymphoma. #oncology https://www.healio.com/hematology-oncology/lymphoma/news/online/{be1b15b6-0755-4ff9-b337-0384adb57369}/pd-l1-alterations-identify-t-cell-inflamed-diffuse-large-b-cell-lymphoma?utm_medium=social&utm_source=twitter&utm_campaign=scheduledpost